SCHEMBL97534

SCHEMBL97534

NS(=O)(=O)CCCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23573874 0.92 HIF1A (0.45)
SCHEMBL14627813 0.90 TSHR (0.44)
SCHEMBL4805974 0.82
SCHEMBL6300989 0.76
SCHEMBL10405537 0.75 CA2 (0.39)
SCHEMBL10457263 0.75 CA2 (0.43)
SCHEMBL7814635 0.72
SCHEMBL25282721 0.72
SCHEMBL3038000 0.72
SCHEMBL8069056 0.72 CA2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008133344-A2 PIPERIDINE DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 WO claimed
US-20080275085-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-06 US claimed
US-20050130228-A1 Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form H. LUNDBECK A/S (DK) 2005-06-16 US claimed
EP-1098659-A4 LIBRARIES OF POLYHYDROXAMATES AND THEIR ANALOGS METAPHORE INC (US) 2004-11-24 EP claimed
EP-1476465-A1 METHOD FOR PRODUCING INTERFERON RMF DICTAGENE S.A. (CH) 2004-11-17 EP claimed
WO-2003070764-A1 METHOD FOR PRODUCING INTERFERON RMF DICTAGENE S.A. (CH) 2003-08-28 WO claimed
US-20030138847-A1 Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form H. LUNDBECK A/S (DK) 2003-07-24 US claimed
CN-1427743-A Dosage forms of polymeric carriers, their use in organic chemical synthesis and process for producing said dosage forms LONDBERK AS H (DK) 2003-07-02 CN claimed
EP-1268050-A2 DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM H. Lundbeck A/S (DK) 2003-01-02 EP claimed
WO-2001068598-A2 DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM H. LUNDBECK A/S (DK) 2001-09-20 WO claimed
EP-1098659-A2 LIBRARIES OF POLYHYDROXAMATES AND THEIR ANALOGS Metaphore, Inc. (US) 2001-05-16 EP claimed
WO-2000004868-A2 LIBRARIES OF POLYHYDROXAMATES AND THEIR ANALOGS METAPHORE, INC. (US) 2000-02-03 WO claimed
US-20240067944-A1 HIGHLY POTENT ISVD COMPOUNDS CAPABLE OF SUBSTITUTING FOR FVIII(A) NOVO NORDISK A/S (DK) 2024-02-29 US disclosed
WO-2023215032-A2 POTENT ANTI-CANCER CYCLOTIDES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2023-11-09 WO disclosed
US-20230331803-A1 CO-AGONISTS OF THE GLP-1 AND AMYLIN RECEPTORS NOVO NORDISK A/S (DK) 2023-10-19 US disclosed
WO-2023133517-A1 SUBDERMAL IMPLANT FOR SUSTAINED DRUG DELIVERY OAK CREST INSTITUTE OF SCIENCE (US) 2023-07-13 WO disclosed
WO-1999043657-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed
WO-1999040435-A1 PROTEIN FOLDING INHIBITORS NETZER WILLIAM J (US) 1999-08-12 WO disclosed
WO-1998053813-A1 CARBOHYDRATE SCAFFOLD COMPOUNDS AND LIBRARIES INCARA PHARMACEUTICALS CORP. (US) 1998-12-03 WO disclosed
WO-1998051697-A2 METHOD FOR PRODUCING POLYMERS HAVING NUCLEO-BASES AS SIDE-GROUPS MORPHOCHEM AG (DE) 1998-11-19 WO disclosed